ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Robotic-assisted total knee arthroplasty does not increase procedure duration or adverse event incidence: a retrospective comparative cohort study in a secondary public hospital.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTotal knee arthroplasty (TKA) with various guidance methods for bone cuts and soft-tissue balancing yields excellent outcomes for end-stage knee osteoarthritis, offering durable pain relief and functional restoration. However, there is a growing interest in further enhancing intraoperative accuracy and consistency, with the aim of reducing complications and reducing recovery times through the introduction of robotic-assisted surgery (RAS). As with any new technology, concerns remain regarding the surgeon learning curve, operative efficiency, and safety profile of RAS compared to conventional techniques. This study evaluates the clinical utility of a RAS system (ROSA, Zimmer Biomet) in a public hospital setting, assessing its impact on procedure duration and adverse event incidence at 90 days postoperatively.
methodsA retrospective comparative cohort study was conducted at a secondary public hospital (Queen Elizabeth II Jubilee Hospital) in, Brisbane, Australia. Data was extracted from a departmental registry, electronic medical records, and intraoperative reports from September 2017 to February 2023. The study included 568 TKA cases: 173 instrumented or navigated TKAs performed before RAS introduction (Pre-RAS), 258 robotic-assisted TKAs after RAS adoption (RAS group), and 137 TKAs performed by other department surgeons who did not use RAS (non-RAS), serving as a benchmark for department-wide outcomes. The primary outcomes were procedure duration and adverse event incidence including surgical site infection (SSI), venous thromboembolism (VTE), knee stiffness, and all-cause readmission within 90 days postoperatively.
resultsAmong 67 recorded adverse events, no significant differences in total adverse event incidence were observed between the pre-RAS and RAS groups (12.1% vs. 11.6%, p = 0.78). A non-significant increase in superficial infections in males undergoing RAS-TKA was observed (p = 0.062). The pre-RAS group had significantly longer operative times than the RAS group (128 ± 21.6 min vs. 121.4 ± 19.5 min, p < 0.01). The non-RAS department group had shorter procedure durations than the pre-RAS group (118.3 ± 20.1 min, p < 0.01).
conclusionRAS-TKA was associated with shorter operative times and a comparable safety profile to non-robotic TKA in this cohort. Further investigation is warranted to determine whether these findings are maintained across different settings and over longer follow-up periods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.